zanamivir
PolandMedications containing this active substance
-
Relenza
Form: powder for inhalation, divided
Active substance Dosage zanamivir 5 mg ATC: J05AH01
Manufacturer: Glaxo Wellcome Production GlaxoSmithKline Trading Services Limited